| The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis A Sood, V Midha, GK Makharia, V Ahuja, D Singal, P Goswami, ... Clinical gastroenterology and hepatology 7 (11), 1202-1209. e1, 2009 | 616 | 2009 |
| Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis GK Makharia, S Srivastava, P Das, P Goswami, U Singh, M Tripathi, ... Official journal of the American College of Gastroenterology| ACG 105 (3 …, 2010 | 275 | 2010 |
| Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective P Das, P Goswami, TK Das, T Nag, V Sreenivas, V Ahuja, SK Panda, ... Virchows Archiv 460, 261-270, 2012 | 107 | 2012 |
| Positive and negative effects of nanoparticles on plants and their applications in agriculture P Goswami, J Mathur Plant Science Today 6 (2), 232-242, 2019 | 92 | 2019 |
| Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria AK Gupta, DS Chauhan, K Srivastava, R Das, S Batra, M Mittal, ... Journal of Communicable Diseases 38 (3), 246, 2006 | 91 | 2006 |
| Comparison of various scoring systems and biochemical markers in predicting the outcome in acute pancreatitis S Vasudevan, P Goswami, U Sonika, B Thakur, V Sreenivas, A Saraya Pancreas 47 (1), 65-71, 2018 | 76 | 2018 |
| PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine CJ Das, G Makharia, R Kumar, M Chawla, P Goswami, R Sharma, ... European journal of nuclear medicine and molecular imaging 34, 2106-2114, 2007 | 60 | 2007 |
| Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? P Goswami, P Das, AK Verma, S Prakash, TK Das, TC Nag, V Ahuja, ... Virchows Archiv 465, 521-530, 2014 | 59 | 2014 |
| Impact of antibiotic-resistant bacterial and fungal infections in outcome of acute pancreatitis P Moka, P Goswami, A Kapil, I Xess, V Sreenivas, A Saraya Pancreas 47 (4), 489-494, 2018 | 55 | 2018 |
| Structural and functional abnormalities in lungs in patients with achalasia GK Makharia, A Seith, SK Sharma, A Sinha, P Goswami, A Aggarwal, ... Neurogastroenterology & Motility 21 (6), 603-e20, 2009 | 54 | 2009 |
| Silica nanoparticles as novel sustainable approach for plant growth and crop protection P Goswami, J Mathur, N Srivastava Heliyon 8 (7), 2022 | 49 | 2022 |
| Mechanism of increased intestinal permeability in acute pancreatitis: alteration in tight junction proteins U Sonika, P Goswami, B Thakur, R Yadav, P Das, V Ahuja, A Saraya Journal of clinical gastroenterology 51 (5), 461-466, 2017 | 33 | 2017 |
| NFIA and GATA3 are crucial regulators of embryonic articular cartilage differentiation PNP Singh, US Yadav, K Azad, P Goswami, V Kinare, A Bandyopadhyay Development 145 (2), dev156554, 2018 | 28 | 2018 |
| Application of agro-waste-mediated silica nanoparticles to sustainable agriculture P Goswami, J Mathur Bioresources and Bioprocessing 9 (1), 9, 2022 | 23 | 2022 |
| Intestinal fatty acid binding protein and citrulline as markers of gut injury and prognosis in patients with acute pancreatitis P Goswami, U Sonika, P Moka, V Sreenivas, A Saraya Pancreas 46 (10), 1275-1280, 2017 | 23 | 2017 |
| The probiotic preparation A Sood, V Midha, GK Makharia, V Ahuja, D Singal, P Goswami, ... VSL, 2009 | 22 | 2009 |
| Severe anemia is associated with intestinal injury in preterm neonates B Ozcan, O Aydemir, DU Isik, AY Bas, N Demirel American Journal of Perinatology 37 (06), 603-606, 2020 | 19 | 2020 |
| Demonstration of gut-barrier dysfunction in early stages of non-alcoholic fatty liver disease: a proof-of-concept study K Kaushal, S Agarwal, S Sharma, P Goswami, N Singh, V Sachdev, ... Journal of Clinical and Experimental Hepatology 12 (4), 1102-1113, 2022 | 17 | 2022 |
| 701 A Randomized, Double-Blind, Placebo-Controlled Trial of a Probiotic Preparation, Vsl# 3, for the Treatment of Mild to Moderate Active Ulcerative Colitis GK Makharia, A Sood, V Midha, V Ahuja, DK Singal, R Arora, S Sood, ... Gastroenterology 4 (134), A-99, 2008 | 15 | 2008 |
| The timing of Start is determined primarily by increased synthesis of the Cln3 activator rather than dilution of the Whi5 inhibitor A Litsios, P Goswami, HM Terpstra, C Coffin, LA Vuillemenot, M Rovetta, ... Molecular biology of the cell 33 (5), rp2, 2022 | 14 | 2022 |
